The matrix metalloproteinase 2 -1575 gene polymorphism is associated with the risk of developing myocardial infarction in Mexican patients

Journal of Atherosclerosis and Thrombosis

Volumn 19, Issue 8, 2012, Pages 718-727

  Pérez Hernández, Nonanzit ^a,b   Vargas Alarcón, Gilberto ^a   Martínez Rodríguez, Nancy ^a   Martínez Ríos, Marco Antonio ^a   Peña Duque, Marco Antonio ^a   de la Peña, Aurora Díaz ^a,c   Valente Acosta, Benjamín ^a   Posadas Romero, Carlos ^a   Medina, Aida ^a   Rodríguez Pérez, José Manuel ^a  

^a INSTITUTO NACIONAL DE CARDIOLOGÍA IGNACIO CHÁVEZ   (Mexico)

^b UNIVERSIDAD AUTÓNOMA DE LA CIUDAD DE MÉXICO   (Mexico)

^c UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

Extracellular matrix; Haplotypes; Matrix metalloproteinase; Myocardial infarction; Polymorphisms

Indexed keywords

PHOSPHODIESTERASE I;

ADULT; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CIGARETTE SMOKING; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DNA POLYMORPHISM; FEMALE; GENDER; GENE; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HEART INFARCTION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MATRIX METALLOPROTEINASE 12-82 GENE; MATRIX METALLOPROTEINASE 2 GENE; MATRIX METALLOPROTEINASE 2-1306 GENE; MATRIX METALLOPROTEINASE 2-1575 GENE; MATRIX METALLOPROTEINASE 2-735 GENE; MATRIX METALLOPROTEINASE 2-790 GENE; MATRIX METALLOPROTEINASE 7-153 GENE; MATRIX METALLOPROTEINASE 7-181 GENE; MEXICO;

EID: 84865734834     PISSN: 13403478     EISSN: 18803873     Source Type: Journal    
DOI: 10.5551/jat.11817     Document Type: Article

References (40)

1. Libby P: Inflammation in atherosclerosis. Nature, 2002; 420: 868-874
2. Virmani R, Kolodgie FD, Burke AP, Finn AV, Gold HK, Tulenko TN, Wrenn SP, Narula J: Atherosclerotic plaque progression and vulnerability to rupture: angiogenesis as a source of intraplaque hemorrhage. Arterioscler Thromb Vasc Biol, 2005; 25: 2054-2061
3. Achar SA, Hundu S, Norcross WA: Diagnosis of acute coronary syndrome. Am Fam Physician, 2005; 72: 119-126
4. Mouco OM, Nicolau JC, Souza Tda R, Maia LN, Ramires JA: Inflammatory markers of atherosclerotic plaque stabilization after acute coronary event-temporal trends. Arq Bras Cardiol, 2006; 87: 28-36
5. Mälarstig A, Wallentin L, Siegbahn: Genetic variation in the interleukin-6 gene in relation to risk and outcomes in acute coronary syndrome. Thromb Res, 2006; 119: 467-473
6. Falk E: Pathogenesis of atherosclerosis. J Am Coll Cardiol, 2006; 47: C7-12
7. Creemers EE, Cleutjens JP, Smits JF, Daemen MJ: Matrix metalloproteinase inhibition after myocardial infarction a new approach to prevent heart failure? Circ Res, 2001; 89: 201-210
8. Newby AC: Dual role of matrix metalloproteinases (matrixins) in intimal thickening and atherosclerotic plaque rupture. Physiol Rev, 2005; 85: 1-31
9. Johnson C, Galis ZS: Matrix metalloproteinase-2 and-9 differentially regulate smooth muscle cell migration and cell-mediated collagen organization. Arterioscler Thromb Vasc Biol, 2004; 24: 54-60
10. Delgado-Enciso I, Gonzalez-Hernandez NA, Baltazar-Rodriguez LM, Millan-Guerrero RO, Newton-Sanchez O, Bayardo-Noriega A, Aleman-Mireles A, Enriquez-Maldonado IG, Anaya-Carrillo MJ, Rojas-Martinez A, Ortiz-Lopez R: Association of matrix metalloproteinase-2 gene promoter polymorphism with myocardial infarction susceptibility in a Mexican population. J Genet, 2009; 88: 249-252
11. Alp E, Menevse S, Tulmac M, Yilmaz A, Yalcin R, Cengel A: The role of matrix metalloproteinase-2 promoter polymorphisms in coronary artery disease and myocardial infarction. Genet Test Mol Biomarkers, 2011; 15: 193-202
12. Terashima M, Akita H, Kanazawa K, Inoue N, Yamada S, Ito K, Matsuda Y, Takai E, Iwai C, Kurogane H, Yoshida Y, Yokoyama M: Stromelysin promoter 5A/6A polymorphism is associated with acute myocardial infarction. Circulation, 1999; 99: 2717-2719
13. Wang L, Ma YT, Xie X, Yang Yn, Fu ZY, Liu F, Li XM, Chen BD: Association of MMP9 gene-1562 C/T polymorphism with myocardial infarction in Uighur population of Xinjang. Zhonghua Yi Xue Yi Chuan Xue Za Zhi, 2011; 28: 180-184
14. Miller SA, Dykes DD, Polesky HF: A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res, 1988; 16: 1215
15. Mtairag el M, Houard X, Rais S, Pasquier C, Oudghri M, Jacob MP, Meilhac O, Michael JB: Pharmacological potentiation of natriuretic peptide limits polymorphonuclear neutrophil-vascular cell interactions. Arterioscler Thromb Vasc Biol, 2002; 22: 1824-1831
16. Davies MJ, Thomas AC: Plaque fissuring-the cause of acute myocardial infarction, sudden ischemic death, and crescendo angina. Br Heart J, 1985; 53: 363-373
17. Ravn HB, Falk E: Histopathology of plaque rupture. Cardiol Clin, 1999; 17: 263-270
18. Ndiaye NC, Azimi Nehzad M, El Shamieh S, Stathopoulou MG, Visvikis-Siest S: Cardiovascular diseases and genome-wide association studies. Clin Chim Acta, 2011; 412: 1697-701
19. Lettre G, Palmer CD, Young T, Ejebe KG, Allayee H, Benjamin EJ, Bennett F, Bowden DW, Chakravarti A, Dreisbach A, Farlow DN, Folsom AR, Fornage M, Forrester T, Fox E, Haiman CA, Hartiala J, Harris TB, Hazen SL, Heckbert SR, Henderson BE, Hirschhorn JN, Keating BJ, Kritchevsky SB, Larkin E, Li M, Rudock ME, McKenzie CA, Meigs JB, Meng YA, Mosley TH, Newman AB, Newton-Cheh CH, Paltoo DN, Papanicolaou GJ, Patterson N, Post WS, Psaty BM, Qasim AN, Qu L, Rader DJ, Redline S, Reilly MP, Reiner AP, Rich SS, Rotter JI, Liu Y, Shrader P, Siscovick DS, Tang WH, Taylor HA, Tracy RP, Vasan RS, Waters KM, Wilks R, Wilson JG, Fabsitz RR, Gabriel SB, Kathiresan S, Boerwinkle E: Genome-wide association study of coronary heart disease and its risk factors in 8,090 African Americans: the NHLBI CARe Project. PLoS Genet, 2011; 7: e1001300
20. Preuss M, König IR, Thompson JR, Erdmann J, Absher D, Assimes TL, Blankenberg S, Boerwinkle E, Chen L, Cupples LA, Hall AS, Halperin E, Hengstenberg C, Holm H, Laaksonen R, Li M, März W, McPherson R, Musunuru K, Nelson CP, Burnett MS, Epstein SE, O'Donnell CJ, Quertermous T, Rader DJ, Roberts R, Schillert A, Stefansson K, Stewart AF, Thorleifsson G, Voight BF, Wells GA, Ziegler A, Kathiresan S, Reilly MP, Samani NJ, Schunkert H; CARDIoGRAM Consortium. Design of the Coronary ARtery DIsease Genome-Wide Replication And Meta-Analysis (CARDIoGRAM) Study: A Genome-wide association meta-analysis involving more than 22 000 cases and 60 000 controls. Circ Cardiovasc Genet, 2010; 3: 475-483
21. Rosenberg NA, Huang L, Jewett EM, Szpiech ZA, Jankovic I, Boehnke M: Genome-wide association studies in diverse populations. Nat Rev Genet, 2010; 11: 356-366
22. Lisker R, Perez-Briceno R, Granados J, Babinsky V: Gene frequencies and admixture estimates in the State of Puebla, Mexico. Am J Phys Anthropol, 1988; 76: 331-335
23. Lisker R, Ramírez E, Pérez G, Díaz R, Siperstein M, Mutchinick O: Genotypes of alcohol-metabolizing enzymes in Mexicans with alcoholic liver cirrhosis. Arch Med Res, 1995; 26: S63-S67
24. Lisker R, Ramírez E, Babinsky V: Genetic structure of autochthonous populations of Meso-America: Mexico. Hum Biol, 1996; 6: 395-404
25. Pöllänen PJ, Karhunen PJ, Mikkelsson J, Laippala P, Perola M, Penttilä A, Mattila KM, Koivula T, Lehtimáki T: Coronary artery complicated lesion area is related to functional polymorphism of matrix metalloproteinase 9 gene: an autopsy study. Arterioscler Thromb Vasc Biol, 2001; 21: 1446-1450
26. Abilleira S, Bevan S, Markus HS: The role of genetics variants of matrix metalloproteinases in coronary and carotid atherosclerosis. J Med Genet, 2006; 43: 897-901
27. Hojo Y, Ikeda U, Ueno S, Arakawa H, Shimada K: Expression of matrix metalloproteinases in patients with acute myocardial infarction. Jpn Circ J, 2001; 65: 71-75
28. Kai H, Ikeda H, Yasukawa H, Kai M, Seki Y, Kuwahara F, Ueno T, Sugi K, Imaizumi T: Peripheral blood levels of matrix metalloproteases-2 and-9 are elevated in patients with acute coronary syndromes. J Am Coll Cardiol, 1998; 32: 368-372
29. Pasterkamp G, Schoneveld AH, Hijnen DJ, de Kleijn DP, Teepen H, van der Wal AC, Borst C: Atherosclerotic arterial remodeling and the localization of macrophages and matrix metalloproteases 1, 2 and 9 in the human coronary artery. Atherosclerosis, 2000; 150: 245-253
30. Harendza S, Lovett DH, Panzer U, Lukacs Z, Kuhnl P, Stahl RA: Linked common polymorphisms in the gelatinase a promoter are associated with diminished transcriptional response to estrogen and genetic fitness. J Biol Chem, 2003; 278: 20490-20499
31. Price SJ, Greaves DR, Watkins H: Identification of novel, functional genetic variants in the human matrix metalloproteinase-2 gene. J Biol Chem, 2001; 276: 7549-7558
32. Quin H, Sun Y, Benveniste EN: The transcription factors Sp1, Sp3, and AP-2 are required for constitutive matrix metalloproteinase-2 gene expression in astroglioma cells. J Biol Chem, 1999; 274: 29130-29137
33. Xu E, Xia X, Lü B, Xing X, Huang Q, Ma Y, Wang W, Lai M: Association of matrix metalloproteinase-2 and-9 promoter polymorphisms with colorectal cancer in Chinese. Mol Carcinog, 2007; 46: 924-929
34. Hua Y, Song L, Wu N, Lu X, Meng X, Gu D, Yang Y: Polymorphisms of MMP-2 gene are associated with systolic heart failure risk in Han Chinese. Am J Med Sci, 2009; 337: 344-348
35. Holla LI, Fassmann A, Vasku A, Goldbergova M, Beranek M, Znojil V, Vanek J, Vacha J: Genetic variations in the human gelatinase A (matrix metalloproteinase-2) promoter are not associated with susceptibility to, and severity of, chronic periodontitis. J Periodontol, 2005; 76: 1056-1060
36. Beránek M, Kolar P, Tschoplova S, Kankova K, Vasku A: Genetic variations and plasma levels of gelatinase A (matrix metalloproteinase-2) and gelatinase B (matrix metalloproteinase-9) in proliferative diabetic retinopathy. Mol Vis, 2008; 14: 1114-1121
37. Vasku V, Bienertova Vasku J, Slonková V, Kanková K, Vaskú A: Matrix metalloproteinase-2 promoter variability in psoriasis. Arch Dermatol Res, 2009; 301: 467-473
38. Vasku V, Goldbergová M, Izakovicová Hollá L, Sisková L, Groch L, Beránek M, Tschöplová S, Znojil V, Vácha J: A haplotype constituted of four MMP-2 promoter polymorphisms (-1575G/A,-1306C/T,-790T/G and-735C/T) is associated with coronary triple-vessel disease. Matrix Biol, 2004; 22: 585-591
39. Horne BD, Camp NJ, Carlquist JF, Muhlestein JB, Kolek MJ, Nicholas ZP, Anderson JL: Multiple-polymorphism associations of 7 matrix metalloproteinase and tissue inhibitor metalloproteinase genes with myocardial infarction and angiographic coronary artery disease. Am Heart J, 2007; 154: 751-758
40. Jormsjö S, Ye S, Moritz J, Walter DH, Dimmeler S, Zeiher AM, Henney A, Hamsten A, Eriksson P: Allele-specific regulation of matrix metalloproteinase-12 gene activity is associated with coronary artery luminal dimensions in diabetic patients with manifest coronary artery disease. Circ Res, 2000; 86: 998-1003